Association analysis of ANK3 gene variants in nordic bipolar disorder and schizophrenia case-control samples

Am J Med Genet B Neuropsychiatr Genet. 2011 Dec;156B(8):969-74. doi: 10.1002/ajmg.b.31244. Epub 2011 Oct 3.

Abstract

Genetic variants in ankyrin 3 (ANK3) have recently been shown to be associated with bipolar disorder (BD). We genotyped three ANK3 SNPs previously found to be associated with BD (rs10994336, rs1938526, and rs9804190) in a Scandinavian BD case-control sample (N = 854/2,614). Due to evidence of genetic overlap between BD and schizophrenia (SZ), we also genotyped these three SNPs in a Scandinavian SZ case-control sample (N = 1,073/2,919). Combining our Scandinavian samples with an Icelandic sample (N = 435 BD cases, 651 SZ cases, and 11,491 healthy controls), we found rs10994336 and rs9804190 to be nominally significantly associated with BD in this combined Nordic BD sample (N = 1,289/14,105). Nominal P was 0.015/0.018 (fixed/random effect) for rs10994336 (Bonferroni corrected P = 0.044/0.053) and 0.023 for rs9804190 (Bonferroni corrected P = 0.069). None of the SNPs were significantly associated with SZ in the combined Nordic SZ case-control sample (N = 1,724/14,410). These results further support that ANK3 is a susceptibility gene specific to BD and that more than one risk locus is involved.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ankyrins / genetics*
  • Bipolar Disorder / genetics*
  • Case-Control Studies
  • Female
  • Gene Frequency
  • Genetic Association Studies*
  • Genetic Predisposition to Disease
  • Genetic Variation
  • Genotype
  • Humans
  • Iceland
  • Male
  • Polymorphism, Single Nucleotide
  • Scandinavian and Nordic Countries
  • Schizophrenia / genetics*

Substances

  • ANK3 protein, human
  • Ankyrins